In-Vitro Diagnostics Instruments Global Market Report 2025
상품코드:1877803
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
체외진단 기기 시장 규모는 최근 몇 년 동안 크게 성장했습니다. 2024년 555억 9,000만 달러로 평가되었고, 2025년에는 610억 9,000만 달러에 달하고, CAGR 9.9%로 성장할 것으로 예상됩니다. 지난 몇 년간의 성장은 만성 질환 증가, 자동화 검사 시스템의 보급 확대, 예방 의료에의 의식 향상, 병원 및 진료소의 인프라 확충, 의료 시책에 대한 정부 자금 증가 등의 요인에 의해 견인되어 왔습니다.
체외진단 기기 시장 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년에는 901억 3,000만 달러에 달하고, CAGR은 10.2%를 나타낼 전망입니다. 예측 기간 동안의 성장은 맞춤형 의료에 대한 수요 증가, 신속 진단 검사 수요 증가, 재택 진단 수요 증가, 항균제 내성 인식 향상으로 인한 것입니다. 예측기간의 주요 동향으로는 소형화 진단장치의 개발, 고처리량 플랫폼의 진보, 전자건강기록과의 통합, 검사실에서의 로봇기술의 도입, 바이오센서기술의 혁신 등이 있습니다.
만성질환 및 생활습관병의 유병률 상승은 향후 수년간 체외진단 기기 시장의 성장을 가속할 것으로 예측됩니다. 만성 질환 및 생활 습관병은 주로 일상적인 습관, 행동, 환경 요인(심장 질환, 당뇨병, 비만, 특정 암 등)에 의해 영향을 받는 장기적인 건강 상태를 말합니다. 이러한 질병의 발생률은 앉기 쉬운 생활 양식과 건강에 해로운 식습관에 의해 증가하고 있습니다. 체외진단 기기 수요가 높아지고 있는 배경에는 만성 질환 및 생활 습관병 증가에 수반하는 질병 관리의 개선을 목적으로 한 조기 발견 및 모니터링 툴의 도입이 기업간에서 촉진되고 있는 것을 들 수 있습니다. 예를 들어 미국에 거점을 둔 비영리·중도우파 싱크탱크 '아메리칸 액션 포럼'에 따르면 2024년 현재 만성질환은 미국에서 주요 공중위생 우려사항이며 성인의 약 60%가 적어도 하나의 질환을 갖고 40%가 여러 질병을 관리하고 있으며, 2050년까지 게다가 만성 질환 치료 시장은 2025년 97억 4,000만 달러에서 2034년까지 약 380억 2,000만 달러에 이를 것으로 예측됩니다. 따라서 만성질환과 생활습관병 증가세는 체외진단 기기 시장의 성장을 가속하고 있습니다.
체외진단 기기 시장에서 사업을 전개하는 주요 기업은 차세대 진단을 위한 고정밀·고감도의 핵산 정량을 실현하기 위해 디지털 중합효소 연쇄반응(dPCR) 시스템 등의 선진기술 개발에 주력하고 있습니다. 디지털 중합효소 연쇄반응(dPCR) 시스템은 샘플을 수천 개의 개별 반응으로 분할하여 DNA 또는 RNA 분자를 정량화하는 고급 진단 장비로, 감지에 탁월한 정확성과 감도를 제공합니다. 예를 들어 2024년 9월, 네덜란드에 본사를 둔 바이오테크놀러지 기업 QIAGEN NV는 QIAcuityDx 디지털 PCR 시스템을 발표하고 주로 종양 검사에 초점을 맞춘 임상 진단 분야로 dPCR 제품군을 확대했습니다. 이 완전 통합 자동 시스템은 임상 사용을 고려하여 설계되었으며 카트리지 기반 워크플로우를 통해 수동 작동을 최소화합니다. 자동 해석 보고 소프트웨어를 탑재한 QIAcuityDx는 암 진단이나 치료 모니터링을 위한 유전자 바이오마커를 신속하고 정확하게 감지합니다. 운영자의 참여를 줄이면서 신뢰성이 높고 반복 가능한 결과를 보장합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 체외진단 기기 시장 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 체외진단 기기 시장 : 성장률 분석
세계의 체외진단 기기 시장 실적 : 규모와 성장, 2019-2024
세계의 체외진단 기기 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 체외진단 기기 시장 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 체외진단 기기 시장 : 제품 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
임상 화학
면역 측정
분자진단
혈액학
미생물학
응고
기타 제품 유형
세계의 체외진단 기기 시장 : 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
감염증
암
심장병학
신장학
자가면역질환
기타 용도
세계의 체외진단 기기 시장 : 최종 사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
병원 및 진단실험실
학술연구기관
포인트 오브 케어 환경
혈액은행
제약 및 생명 공학 기업
기타 의료시설
세계의 체외진단 기기 시장 : 세분화 임상 화학, 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
자동 임상 화학 분석 장치
반자동 임상 화학 분석 장치
포인트 오브 케어 임상 화학 장치
세계의 체외진단 기기 시장 : 세분화 면역 측정, 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
효소 면역 측정법(ELISA) 시스템
화학발광 면역측정법(CLIA) 분석 장치
라디오 면역분석(RIA) 시스템
세계의 체외진단 기기 시장 : 세분화 분자진단, 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
중합효소 연쇄반응(PCR) 시스템
차세대 시퀀싱(NGS) 플랫폼
Deoxyribonucleic Acid Microarrays
등온 증폭 장치
세계의 체외진단 기기 시장 : 세분화 혈액학, 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
자동 혈액 분석 장치
수동 혈액 분석 장치
지혈 분석 기기
응고 분석 기기
세계의 체외진단 기기 시장 : 세분화 미생물학, 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
미생물 식별 시스템
항균제 감수성 시험(AST) 시스템
혈액 배양 시스템
자동 미생물 분석기.
세계의 체외진단 기기 시장 : 세분화 응고, 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
응고 측정 장치
혈소판 기능 분석 장치
트롬보엘라스토그래피(TEG) 시스템
포인트 오브 케어 응고 측정 장치
세계의 체외진단 기기 시장 : 세분화 기타 제품 유형, 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
POC(Point of Care) 진단 장치
임상 화학 시약
진단용 화상 기기
기타 검사 기기
제7장 지역별/국가별 분석
세계의 체외진단 기기 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
세계의 체외진단 기기 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
체외진단 기기 시장 : 경쟁 구도
체외진단 기기 시장 : 기업 프로파일
F. Hoffmann-La Roche Ltd : 개요, 제품 및 서비스, 전략 및 재무 분석
Danaher Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
Abbott Laboratories : 개요, 제품 및 서비스, 전략 및 재무 분석
Thermo Fisher Scientific : 개요, 제품 및 서비스, 전략 및 재무 분석
Siemens Healthineers AG : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Illumina Inc.
Hologic Inc.
Qiagen NV
Bio-Rad Laboratories Inc.
Agilent Technologies
Becton Dickinson and Company(BD)
Sysmex Corporation
Laboratory Corporation of America Holdings(LabCorp)
Guardant Health Inc.
Quest Diagnostics Inc.
Exact Sciences Corporation
Myriad Genetics Inc.
Natera Inc.
NeoGenomics Laboratories Inc.
NanoString Technologies Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
체외진단 기기 시장 2029 : 새로운 기회를 제공하는 국가
체외진단 기기 시장 2029 : 새로운 기회를 제공하는 부문
체외진단 기기 시장 2029 : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
SHW
영문 목차
영문목차
In-vitro diagnostic instruments are medical devices used to analyze biological samples, such as blood, urine, or tissue, outside the human body. Their primary function is to detect, diagnose, monitor, and manage diseases or medical conditions by providing accurate and timely laboratory test results. These instruments aid clinical decision-making and support personalized patient care.
The primary product types of in-vitro diagnostic instruments include clinical chemistry, immunoassay, molecular diagnostics, hematology, microbiology, coagulation, and others. Clinical chemistry instruments are digital tools, often leveraging AI, to analyze blood, urine, and other body fluids, helping identify biochemical abnormalities, improve diagnostic accuracy, and guide treatment planning. These instruments are applied across multiple areas, including infectious diseases, cancer, cardiology, nephrology, and autoimmune disorders. They serve a diverse range of end users, including hospitals, diagnostic laboratories, academic and research institutes, point-of-care facilities, blood banks, and pharmaceutical and biotechnology companies.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.
The in-vitro diagnostics instruments market research report is one of a series of new reports from The Business Research Company that provides in-vitro diagnostics instruments market statistics, including in-vitro diagnostics instruments industry global market size, regional shares, competitors with a in-vitro diagnostics instruments market share, detailed in-vitro diagnostics instruments market segments, market trends and opportunities, and any further data you may need to thrive in the in-vitro diagnostics instruments industry. This in-vitro diagnostics instruments market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The in-vitro diagnostics instruments market size has grown strongly in recent years. It will grow from $55.59 billion in 2024 to $61.09 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth during the historic period is driven by increasing prevalence of chronic diseases, growing adoption of automated laboratory systems, rising awareness of preventive healthcare, increasing hospital and clinic infrastructure, and growing government funding for healthcare initiatives.
The in-vitro diagnostics instruments market size is expected to see rapid growth in the next few years. It will grow to $90.13 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth during the forecast period is driven by the increasing demand for personalized medicine, growing demand for rapid diagnostic tests, rising demand for home-based diagnostics, and increasing awareness of antimicrobial resistance. Primary trends in the forecast period include the development of miniaturized diagnostic devices, advancement in high-throughput platforms, integration with electronic health records, incorporation of robotics in laboratories, and innovation in biosensor technologies.
The rising prevalence of chronic and lifestyle related diseases is expected to enhance the growth of the in vitro diagnostics instruments market in the coming years. Chronic and lifestyle related diseases refer to long term health conditions primarily influenced by daily habits, behaviors, and environmental factors, such as heart disease, diabetes, obesity, and certain cancers. The incidence of these diseases is increasing due to sedentary lifestyles and unhealthy dietary habits. In vitro diagnostics instruments are experiencing higher demand as the growing burden of chronic and lifestyle related diseases encourages companies to adopt early detection and monitoring tools for improved disease management. For example, in 2024, according to the American Action Forum, a U.S. based non profit, center right think tank, chronic diseases remain a major public health concern in the United States, with nearly 60 percent of adults living with at least one condition, 40 percent managing multiple conditions, and prevalence expected to nearly double by 2050. Furthermore, the chronic disease treatment market is projected to reach approximately 38.02 billion dollars by 2034, up from 9.74 billion dollars in 2025. Therefore, the rising prevalence of chronic and lifestyle related diseases is enhancing the growth of the in vitro diagnostics instruments market.
Prominent companies operating in the in-vitro diagnostics instruments market are focusing on developing advanced technologies, such as digital polymerase chain reaction (dPCR) systems, to achieve highly precise and sensitive nucleic acid quantification for next-generation diagnostics. Digital polymerase chain reaction (dPCR) systems are sophisticated diagnostic instruments that quantify DNA or RNA molecules by dividing samples into thousands of individual reactions, allowing for exceptional accuracy and sensitivity in detection. For example, in September 2024, QIAGEN N.V., a Netherlands-based biotechnology company, introduced the QIAcuityDx Digital PCR System, expanding its dPCR portfolio into clinical diagnostics with a primary focus on oncology testing. This fully integrated and automated system is specifically designed for clinical use, featuring a cartridge-based workflow that minimizes manual handling. Equipped with automated analysis and reporting software, the QIAcuityDx enables rapid and precise detection of genetic biomarkers for cancer diagnosis and therapy monitoring, reducing operator involvement while ensuring reliable and reproducible results.
In January 2025, Fremman Ltd., a UK-based investment company, acquired a majority stake in DIESSE Diagnostica Senese S.p.A. for an undisclosed amount. Through this acquisition, Fremman Ltd aims to expand DIESSE Diagnostica Senese's international presence, strengthen its leadership in specialty in vitro diagnostics, and support ongoing innovation to advance global diagnostic capabilities and improve patient outcomes. DIESSE Diagnostica Senese S.p.A. is an Italy-based medical equipment company that provides in vitro diagnostic instruments.
Major players operating in the in-vitro diagnostics instruments market are F. Hoffmann-La Roche Ltd, Danaher Corporation, Abbott Laboratories, Thermo Fisher Scientific, Siemens Healthineers AG, Illumina Inc., Hologic Inc., Qiagen N.V., Bio-Rad Laboratories Inc., Agilent Technologies, Becton, Dickinson and Company (BD), Sysmex Corporation, Laboratory Corporation of America Holdings (LabCorp), Guardant Health Inc., Quest Diagnostics Inc., Exact Sciences Corporation, Myriad Genetics Inc., Natera Inc., NeoGenomics Laboratories Inc., NanoString Technologies Inc., Veracyte Inc., Invitae Corporation, Foundation Medicine Inc. (Roche), Caris Life Sciences, Personalis Inc., OncoCyte Corporation, Freenome Holdings Inc., Epic Sciences Inc.
North America was the largest region in the in-vitro diagnostics instruments market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro diagnostics instruments market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the in-vitro diagnostics instruments market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The in-vitro diagnostics instruments market consists of sales of point-of-care testing devices, flow cytometry instruments, histopathology and cytology instruments, and molecular point-of-care systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
In-Vitro Diagnostics Instruments Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on in-vitro diagnostics instruments market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for in-vitro diagnostics instruments ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The in-vitro diagnostics instruments market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Clinical Chemistry; Immunoassay; Molecular Diagnostics; Hematology; Microbiology; Coagulation; Other Product Types
2) By Application: Infectious Diseases; Cancer; Cardiology; Nephrology; Autoimmune Diseases; Other Applications
3) By End User: Hospitals And Diagnostic Laboratories; Academic And Research Institutes; Point-Of-Care Settings; Blood Banks; Pharmaceutical And Biotechnology Companies; Other Healthcare Facilities
3. In-Vitro Diagnostics Instruments Market Trends And Strategies
4. In-Vitro Diagnostics Instruments Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global In-Vitro Diagnostics Instruments Growth Analysis And Strategic Analysis Framework
5.1. Global In-Vitro Diagnostics Instruments PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global In-Vitro Diagnostics Instruments Market Growth Rate Analysis
5.4. Global In-Vitro Diagnostics Instruments Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global In-Vitro Diagnostics Instruments Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global In-Vitro Diagnostics Instruments Total Addressable Market (TAM)
6.1. Global In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clinical Chemistry
Immunoassay
Molecular Diagnostics
Hematology
Microbiology
Coagulation
Other Product Types
6.2. Global In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Infectious Diseases
Cancer
Cardiology
Nephrology
Autoimmune Diseases
Other Applications
6.3. Global In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Diagnostic Laboratories
Academic And Research Institutes
Point-Of-Care Settings
Blood Banks
Pharmaceutical And Biotechnology Companies
Other Healthcare Facilities
6.4. Global In-Vitro Diagnostics Instruments Market, Sub-Segmentation Of Clinical Chemistry, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Automated Clinical Chemistry Analyzers
Semi-Automated Clinical Chemistry Analyzers
Point-Of-Care Clinical Chemistry Devices
6.5. Global In-Vitro Diagnostics Instruments Market, Sub-Segmentation Of Immunoassay, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Enzyme-Linked Immunosorbent Assay (ELISA) Systems
Chemiluminescence Immunoassay (CLIA) Analyzers
Radioimmunoassay (RIA) Systems
6.6. Global In-Vitro Diagnostics Instruments Market, Sub-Segmentation Of Molecular Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polymerase Chain Reaction (PCR) Systems
Next-Generation Sequencing (NGS) Platforms
Deoxyribonucleic Acid Microarrays
Isothermal Amplification Devices
6.7. Global In-Vitro Diagnostics Instruments Market, Sub-Segmentation Of Hematology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Automated Hematology Analyzers
Manual Hematology Analyzers
Hemostasis Analyzers
Coagulation Analyzers
6.8. Global In-Vitro Diagnostics Instruments Market, Sub-Segmentation Of Microbiology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Microbial Identification Systems
Antibiotic Susceptibility Testing (AST) Systems
Blood Culture Systems
Automated Microbial Analyzers.
6.9. Global In-Vitro Diagnostics Instruments Market, Sub-Segmentation Of Coagulation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Coagulometers
Platelet Function Analyzers
Thromboelastography (TEG) Systems
Point-Of-Care Coagulation Devices
6.10. Global In-Vitro Diagnostics Instruments Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Point-Of-Care Diagnostic Devices
Clinical Chemistry Reagents
Diagnostic Imaging Instruments
Miscellaneous Laboratory Instruments
7. In-Vitro Diagnostics Instruments Market Regional And Country Analysis
7.1. Global In-Vitro Diagnostics Instruments Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global In-Vitro Diagnostics Instruments Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China In-Vitro Diagnostics Instruments Market
9.1. China In-Vitro Diagnostics Instruments Market Overview
9.2. China In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India In-Vitro Diagnostics Instruments Market
10.1. India In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan In-Vitro Diagnostics Instruments Market
11.1. Japan In-Vitro Diagnostics Instruments Market Overview
11.2. Japan In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia In-Vitro Diagnostics Instruments Market
12.1. Australia In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia In-Vitro Diagnostics Instruments Market
13.1. Indonesia In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea In-Vitro Diagnostics Instruments Market
14.1. South Korea In-Vitro Diagnostics Instruments Market Overview
14.2. South Korea In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe In-Vitro Diagnostics Instruments Market
15.1. Western Europe In-Vitro Diagnostics Instruments Market Overview
15.2. Western Europe In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK In-Vitro Diagnostics Instruments Market
16.1. UK In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.1. Germany In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France In-Vitro Diagnostics Instruments Market
18.1. France In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy In-Vitro Diagnostics Instruments Market
19.1. Italy In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain In-Vitro Diagnostics Instruments Market
20.1. Spain In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe In-Vitro Diagnostics Instruments Market
21.1. Eastern Europe In-Vitro Diagnostics Instruments Market Overview
21.2. Eastern Europe In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia In-Vitro Diagnostics Instruments Market
22.1. Russia In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America In-Vitro Diagnostics Instruments Market
23.1. North America In-Vitro Diagnostics Instruments Market Overview
23.2. North America In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA In-Vitro Diagnostics Instruments Market
24.1. USA In-Vitro Diagnostics Instruments Market Overview
24.2. USA In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America In-Vitro Diagnostics Instruments Market
26.1. South America In-Vitro Diagnostics Instruments Market Overview
26.2. South America In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil In-Vitro Diagnostics Instruments Market
27.1. Brazil In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East In-Vitro Diagnostics Instruments Market
28.1. Middle East In-Vitro Diagnostics Instruments Market Overview
28.2. Middle East In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa In-Vitro Diagnostics Instruments Market
29.1. Africa In-Vitro Diagnostics Instruments Market Overview
29.2. Africa In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. In-Vitro Diagnostics Instruments Market Competitive Landscape And Company Profiles
